Shi, R.; Bao, X.; Rogowski, P.; Schäfer, C.; Schmidt-Hegemann, N.-S.; Unger, K.; Lu, S.; Sun, J.; Buchner, A.; Stief, C.;
et al. Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer. Cancers 2020, 12, 1146.
https://doi.org/10.3390/cancers12051146
AMA Style
Shi R, Bao X, Rogowski P, Schäfer C, Schmidt-Hegemann N-S, Unger K, Lu S, Sun J, Buchner A, Stief C,
et al. Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer. Cancers. 2020; 12(5):1146.
https://doi.org/10.3390/cancers12051146
Chicago/Turabian Style
Shi, Run, Xuanwen Bao, Paul Rogowski, Christian Schäfer, Nina-Sophie Schmidt-Hegemann, Kristian Unger, Shun Lu, Jing Sun, Alexander Buchner, Christian Stief,
and et al. 2020. "Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer" Cancers 12, no. 5: 1146.
https://doi.org/10.3390/cancers12051146
APA Style
Shi, R., Bao, X., Rogowski, P., Schäfer, C., Schmidt-Hegemann, N.-S., Unger, K., Lu, S., Sun, J., Buchner, A., Stief, C., Belka, C., & Li, M.
(2020). Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer. Cancers, 12(5), 1146.
https://doi.org/10.3390/cancers12051146
